Here is a list of our most recent publications:

2025

Byanyima W, Bekker LG, Kavanagh MM. Long-Acting HIV Medicines and the Pandemic Inequality Cycle – Rethinking Access. N Engl J Med. 2025 Jan 2;392(1):90-96. doi: 10.1056/NEJMms2412286. Epub 2024 Dec 9. PMID: 39655781.
Graybill LA, McKay CN, Wang J, Sam-Agudu NA, Yotebieng M, Saidi F, Bekker LG, Shook-Sa BE, Chi BH, Rosenberg NE. Characterizing populations prioritized for PrEP in 19 African countries: a review of national guidance. J Int AIDS Soc. 2025 Jan;28(1):e26407. doi: 10.1002/jia2.26407. PMID: 39757425; PMCID: PMC11702491.
Irie WC, Nicol MR, Clement M, Bukusi EA, Bekker LG, Molina JM, Stewart J. Event-driven PrEP beyond cisgender men who have sex with men. Lancet HIV. 2025 Jan 6:S2352-3018(24)00300-X. doi: 10.1016/S2352-3018(24)00300-X. Epub ahead of print. PMID: 39788131.

2024

Atoyebi S, Montanha MC, Nakijoba R, Orrell C, Mugerwa H, Siccardi M, Denti P, Waitt C. Physiologically based pharmacokinetic modeling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy. CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1967-1977. doi: 10.1002/psp4.13268. Epub 2024 Nov 8. PMID: 39517110; PMCID: PMC11578135.
Atujuna M, Williams K, Roberts ST, Young A, Browne EN, Mangxilana NT, Tenza S, Shapley-Quinn MK, Tauya T, Ngure K, van der Straten A. We choose: Adolescent girls and young women’s choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe. PLoS One. 2024 Aug 29;19(8):e0308577. doi: 10.1371/journal.pone.0308577. PMID: 39208281; PMCID: PMC11361692.
Banholzer N, Schmutz R, Middelkoop K, Hella J, Egger M, et al. (2024) Airborne transmission risks of tuberculosis and COVID-19 in schools in South Africa, Switzerland, and Tanzania: Modeling of environmental data. PLOS Global Public Health 4(1): e0002800. https://doi.org/10.1371/journal.pgph.0002800
Beauchamp G, Hosek S, Donnell D, Chan KCG, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C; HPTN 082 study team. The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082. AIDS Behav. 2024 May;28(5):1512-1521. doi: 10.1007/s10461-023-04175-0. Epub 2023 Sep 28. PMID: 37768427; PMCID: PMC11069481.
Bekker C, Dewandel I, Redfern A, McKenzie C, Lishman J, Verhagen LM, Claassen M, Wilson S, Dunbar R, Bosch C, van Zyl G, Preiser W, Goussard P, Rabie H, van der Zalm MM. Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa. IJTLD Open. 2024 Jan 1;1(1):27-33. doi: 10.5588/ijtldopen.23.0053. PMID: 38919411; PMCID: PMC11189602.
Bekker LG, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, Gill K, Harkoo I, Jaggernath M, Kigozi G, Kiwanuka N, Kotze P, Lebina L, Louw CE, Malahleha M, Manentsa M, Mansoor LE, Moodley D, Naicker V, Naidoo L, Naidoo M, Nair G, Ndlovu N, Palanee-Phillips T, Panchia R, Pillay S, Potloane D, Selepe P, Singh N, Singh Y, Spooner E, Ward AM, Zwane Z, Ebrahimi R, Zhao Y, Kintu A, Deaton C, Carter CC, Baeten JM, Matovu Kiweewa F; PURPOSE 1 Study Team. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women. N Engl J Med. 2024 Oct 3;391(13):1179-1192. doi: 10.1056/NEJMoa2407001. Epub 2024 Jul 24. PMID: 39046157.
Bekker LG, Wood R. Strategic planning for the second era of the HIV epidemic. Lancet Public Health. 2024;9(4):e208-e209. doi:10.1016/S2468-2667(24)00051-3
Beyrer C, Tomaras GD, Gelderblom HC, Gray GE, Janes HE, Bekker LG, Millett G, Pantaleo G, Buchbinder S, Corey L. Is HIV epidemic control by 2030 realistic? Lancet HIV. 2024 Jul;11(7):e489-e494. doi: 10.1016/S2352-3018(24)00098-5.PMID: 38925732
Bezuidenhout C, Long L, Nichols B, Meyer-Rath G, Fox MP, Olifant S, Theron G, Fiphaza K, Ruhwald M, Penn-Nicholson A, Fourie B, Medina-Marino A. USING SPUTUM AND TONGUE SWAB SPECIMENS FOR IN-HOME POINT-OF-CARE TARGETED UNIVERSAL TESTING FOR TB OF HOUSEHOLD CONTACTS: AN ACCEPTABILITY AND FEASIBILITY ANALYSIS. medRxiv [Preprint]. 2024 Nov 2:2024.11.01.24316570. doi: 10.1101/2024.11.01.24316570. PMID: 39574838; PMCID: PMC11581095.
Bezuidenhout C, Long L, Nichols B, Meyer-Rath G, Fox MP, Theron G, Fourie B, Olifant S, Penn-Nicholson A, Ruhwald M, Medina-Marino A. Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysis. medRxiv [Preprint]. 2024 Oct 18:2024.10.18.24315746. doi: 10.1101/2024.10.18.24315746. PMID: 39484233; PMCID: PMC11527052.
Bondarchuk C, Lemon T, Medina-Marino A, Rousseau E, Sindelo S, Sibanda N, Butler L, Bekker LG, Earnshaw V, Katz I. The COVID-19 pandemic, food insecurity, and psychosocial well-being in young South Africans newly diagnosed with HIV: a mediation analysis. Res Sq [Preprint]. 2024 Jun 27:rs.3.rs-4560188. doi: 10.21203/rs.3.rs-4560188/v1.PMID: 38978584 [pre-print]
Bondarchuk CP, Lemon T, Medina-Marino A, Rousseau E, Sindelo S, Sibanda N, Butler LM, Bekker LG, Earnshaw VA, Katz IT. Food insecurity and unemployment as mediators of the relationship between the COVID-19 pandemic and psychological well-being in young South Africans with HIV. BMC Public Health. 2024 Sep 27;24(1):2622. doi: 10.1186/s12889-024-19966-w. PMID: 39333961; PMCID: PMC11437656.
Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O’Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; United States Government (USG)/CoVPN Biostatistics Team. Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial. Nat Commun. 2024 Nov 12;15(1):9785. doi: 10.1038/s41467-024-53727-y. PMID: 39532861; PMCID: PMC11557889.
Chandiwana N, Venter W, Manne-Goehler J, Wade A, Le Roux C, Mbalati N, Grimbeek A, Kruger P, Montsho E, Zimela Z, Yawa A, Tshabalala S, Rambau N, Mpofu N, Stevenson S, McNulty B, Ntusi N, Pillay Y, Dave J, Murphy A, Goldstein S, Hfman K, Mahomedy S, Thomas E, Mrara B, Wing J, Lubbe J, Koto Z, Conradie-Smit M, Wharton S, May W, Marr I, Kaplan H, Forgan M, Alexander G, Turner J, Fourie VR, Hellig J, Banks M, Ragsdale K, Noeth M, Mohamed F, Myer L, Lebina L, Maswime S, Moosa Y, Thomas S, Mbelle M, Sinxadi P, Bekker LG, Bhana S, Fabian J, Decloedt E, Bayat Z, Daya R, Bobat B, Storie F, Goedecke J, Kahn K, Tollman S, Mansfield B, Siedner M, Marconi V, Mody A, Mtshali N, Geng E, Srinivasa S, Ali M, Lalla-Edwards S, Bentley A, Wolvaardt G, Hill A, Nel J. Obesity is South Africa’s new HIV epidemic. S Afr Med J. 2024 Mar 18;114(3):e1927. doi: 10.7196/SAMJ.2024.v114i3.1927. PMID: 38525565.
Charalambous S, Malaba N, Jennings L, Rabothatha I, Cogill D, Mukora K, Hippner, P, Naidoo P, Xaba N, Mchunu L, Velen K, Orrell C, Fielding K. Treatment adherence and clinical outcomes amongst people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard of care in South Africa: a cluster randomized trial. eClinicalMedicine, Volume 75, Jun, 2024
Chihana R, Jin Kee J, Moodie Z, Huang Y, Janes H, Dadabhai S, Roxby AC, Allen M, Kassim S, Naicker V, Innes C, Naicker N, Dubula T, Grunenberg N, Malahleha M, Kublin JG, Bekker LG, Gray G, Kumwenda J, Laher F. Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702. Vaccine. 2024 Aug 13;42(20):125991. doi: 10.1016/j.vaccine.2024.05.039. Epub 2024 May 21. PMID: 38772835; PMCID: PMC11320363.
Coakley C, Lee D, Pike C, Myers L, Hartmann M, Oduro A, Ntlapo N, Bekker LG; Youth Investigators of the Goals for Girls study. Realising agency: insights from participatory research with learners in a South African sexual and reproductive health programme. Front Public Health. 2024 Oct 9;12:1329425. doi: 10.3389/fpubh.2024.1329425. PMID: 39450389; PMCID: PMC11499621.
Comfort AB, Asiimwe S, Amaniyre G, Orrell C, Moody J, Musinguzi N, Bwana MB, Bangsberg DR, Haberer JE, Tsai AC; META Study Investigators. Social networks and HIV treatment adherence among people with HIV initiating treatment in rural Uganda and peri-urban South Africa. SSM Popul Health. 2024 Jan 1;25:101593. doi: 10.1016/j.ssmph.2023.101593. PMID: 38292051; PMCID: PMC10825562
Dal-Ré R, Bekker LG, Jha V, Le Louarn A, Naudet F. Navigating US participant data sharing requirements: implications for international clinical trials. BMJ. 2024 Sep 6;386:e079701. doi: 10.1136/bmj-2024-079701. PMID: 39242115.
Dintwe OB, Ballweber Fleming L, Voillet V, McNevin J, Seese A, Naidoo A, Omarjee S, Bekker LG, Kublin JG, De Rosa SC, Newell EW, Fiore-Gartland A, Andersen-Nissen E, McElrath MJ. Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis. Nat Commun. 2024 Jun 18;15(1):5191. doi: 10.1038/s41467-024-49050-1.PMID: 38890283
Fiore-Gartland A, Srivastava H, Seese A, Day T, Penn-Nicholson A, Luabeya AKK, Du Plessis N, Loxton AG, Bekker LG, Diacon A, Walzl G, Sagawa ZK, Reed SG, Scriba TJ, Hatherill M, Coler R. Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans. Front Immunol. 2024 Sep 24;15:1441944. doi: 10.3389/fimmu.2024.1441944. PMID: 39381003; PMCID: PMC11458388.
Foster I, Biewer A, Vanqa N, Makanda G, Tisile P, Hayward SE, Wademan DT, Anthony MG, Mbuyamba R, Galloway M, Human W, van der Westhuizen HM, Friedland JS, Medina-Marino A, Schoeman I, Hoddinott G, Nathavitharana RR. “This is an illness. No one is supposed to be treated badly”: community-based stigma assessments in South Africa to inform tuberculosis stigma intervention design. BMC Glob Public Health. 2024;2(1):41. doi: 10.1186/s44263-024-00070-5. Epub 2024 Jun 24. PMID: 38919729; PMCID: PMC11194205.
Gandhi M, Glidden DV, Chakravarty D, Wang G, Biwott C, Mogere P, Maina G, Njeru I, Kiptinness C, Okello P, Spinelli MA, Chatterjee P, Velloza J, Ogello V, Medina-Marino A, Okochi H, Mugo NR, Ngure K. Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trial. Lancet HIV. 2024 Aug;11(8):e522-e530. doi: 10.1016/S2352-3018(24)00125-5. Epub 2024 Jul 5. PMID: 38976993.
Gandhi M, Glidden DV, Chakravarty D, Wang G, Biwott C, Mogere P, Maina G, Njeru I, Kiptinness C, Okello P, Spinelli MA, Chatterjee P, Velloza J, Ogello V, Medina-Marino A, Okochi H, Mugo NR, Ngure K. Impact of a point-of-care urine tenofovir assay on adherence to HIV pre-exposure prophylaxis among women in Kenya: a randomised pilot trial. Lancet HIV. 2024 Aug;11(8):e522-e530. doi: 10.1016/S2352-3018(24)00125-5. Epub 2024 Jul 5. PMID: 38976993; PMCID: PMC11376217.
Garrett N, Reddy T, Yende-Zuma N, Takalani A, Woeber K, Bodenstein A, Jonas P, Engelbrecht I, Jassat W, Moultrie H, Bradshaw D, Seocharan I, Odhiambo J, Khuto K, Richardson SI, Omondi MA, Nesamari R, Keeton RS, Riou C, Moyo-Gwete T, Innes C, Zwane Z, Mngadi K, Brumskine W, Naicker N, Potloane D, Badal-Faesen S, Innes S, Barnabas S, Lombaard J, Gill K, Nchabeleng M, Snyman E, Petrick F, Spooner E, Naidoo L, Kalonji D, Naicker V, Singh N, Maboa R, Mda P, Malan D, Nana A, Malahleha M, Kotze P, Allagappen JJ, Diacon AH, Kruger GM, Patel F, Moore PL, Burgers WA, Anteyi K, Leav B, Bekker LG, Gray GE, Goga A; SHERPA study team. Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study. PLOS Glob Public Health. 2024 Dec 5;4(12):e0003260. doi: 10.1371/journal.pgph.0003260. PMID: 39636838; PMCID: PMC11620404.
Gati Mirembe B, Donnell D, Krows M, Zwane Z, Bukusi E, Panchia R, Louw C, Mwelase N, Selepe P, Senne M, Naidoo L, Chihana R, Kasaro M, Nuwagaba-Biribonwoha H, Kotze P, Gill K, MacDonald P, vanHeerden A, Bosman S, Jaggernath M, du Preez P, Ward A, Peters RPH, Delany-Moretlwe S, Peacock S, Johnson R, Caucutt J, Morrison S, Wang G, Gandhi M, Velloza J, Heffron R, Celum C; INSIGHT Study Team. High recent PrEP adherence with point-of-care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort. J Int AIDS Soc. 2024 Dec;27(12):e26389. doi: 10.1002/jia2.26389. PMID: 39653676; PMCID: PMC11628190.
Gie AG, van der Zalm MM, McCollum ED, Browne S, Cotton MF, Goussard P, Innes S. Lung Function in the Second Decade of Life in Children after Early HIV Diagnosis and ART Initiation. Am J Respir Crit Care Med. 2024 Dec 16. doi: 10.1164/rccm.202409-1777RL. Epub ahead of print. PMID: 39680939.
Giovenco D, Pettifor A, Qayiya Y, Jones J, Bekker LG. The Acceptability, Feasibility, and Preliminary Effectiveness of a Courier HIV-Treatment Delivery and SMS Support Intervention for Young People Living With HIV in South Africa. J Acquir Immune Defic Syndr. 2024 Feb 1;95(2):161-169. doi: 10.1097/QAI.0000000000003332. PMID: 37856424; PMCID: PMC10841708.
Giovenco D, Pettifor A, Qayiya Y, Jones J, Bekker LG. The Acceptability, Feasibility, and Preliminary Effectiveness of a Courier HIV-Treatment Delivery and SMS Support Intervention for Young People Living With HIV in South Africa. J Acquir Immune Defic Syndr. 2024 Feb 1;95(2):161-169. doi: 10.1097/QAI.0000000000003332.PMID: 37856424
Gray GE, Mngadi K, Lavreys L, Nijs S, Gilbert PB, Hural J, Hyrien O, Juraska M, Luedtke A, Mann P, McElrath MJ, Odhiambo JA, Stieh DJ, van Duijn J, Takalani AN, Willems W, Tapley A, Tomaras GD, Van Hoof J, Schuitemaker H, Swann E, Barouch DH, Kublin JG, Corey L, Pau MG, Buchbinder S, Tomaka F. Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Infect Dis. 2024 Jul 19;. doi: 10.1016/S1473-3099(24)00358-X. [Epub ahead of print] PubMed PMID: 39038477.
Graybill LA, Westreich D, Maseko B, Phanga T, Nthani T, Vansia D, Chi BH, Daniels JL, Tang JH, Bekker LG, Pettifor AE, Rosenberg NE. The effect of youth-friendly health services on risk of pregnancy among adolescent girls and young women in Lilongwe, Malawi: a secondary analysis of the girl power-Malawi study. Am J Epidemiol. 2024 Jul 11:kwae193. doi: 10.1093/aje/kwae193. Online ahead of print.PMID: 38992859
Hayward SE, Vanqa N, Makanda G, Tisile P, Ngwatyu L, Foster I, Mcinziba AA, Biewer A, Mbuyamba R, Galloway M, Bunyula S, van der Westhuizen HM, Friedland JS, Medina-Marino A, Viljoen L, Schoeman I, Hoddinott G, Nathavitharana RR. “As a patient I do not belong to the clinic, I belong to the community”: co-developing multi-level, person-centred tuberculosis stigma interventions in Cape Town, South Africa. BMC Glob Public Health. 2024;2(1):55. doi: 10.1186/s44263-024-00084-z. Epub 2024 Aug 15. PMID: 39157720; PMCID: PMC11324783.
Huang Y, Alam S, Andersen-Nissen E, Carpp LN, Dintwe OB, Flach BS, Grunenberg N, Laher F, De Rosa SC, Ferrari G, Innes C, Bekker LG, Kublin JG, McElrath MJ, Tomaras GD, Gray GE, Gilbert PB. Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses. Viruses. 2024 Aug 27;16(9):1365. doi: 10.3390/v16091365. PMID: 39339842; PMCID: PMC11437453.
Johnson LF, Myer L, Jamieson L, Meyer-Rath G, Delany-Moretlwe S, Joseph Davey D. The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants. AIDS. 2024 Mar 15;38(4):589-594. doi: 10.1097/QAD.0000000000003803. Epub 2023 Dec 4. PMID: 38016171; PMCID: PMC10906189.
Joseph Davey D, Dadan S, Bheemraj K, Waitt C, Khoo S, Myer L, Wiesner L, Else L, Thompson B, Castel S, Wara N, Anderson PL, Orrell C. Evaluation of pharmacokinetics of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil (TDF) in pregnant and postpartum women in South Africa: PrEP-PP PK study. Antiviral Res. 2024 Nov;231:106014. doi: 10.1016/j.antiviral.2024.106014. Epub 2024 Sep 25. PMID: 39332538.
Joseph Davey DL, Mvududu R, Mashele N, Bheemraj K, Khadka N, Johnson LF, Dean SS, Gorbach P, Bekker LG, Coates TJ, Myer L. Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort study. Lancet HIV. 2024 Nov;11(11):e746-e755. doi: 10.1016/S2352-3018(24)00240-6. PMID: 39477557.
Joseph Davey DL, Nyemba DC, Mvududu R, Mashele N, Johnson L, Bekker LG, Dean SS, Bheemraj K, Coates TJ, Myer L. Pregnancy outcomes following self-reported and objectivemeasured exposure to oral preexposure prophylaxis in South Africa. AIDS. 2024 Jan 1;38(1):75-83. doi: 10.1097/QAD.0000000000003729. Epub 2023 Nov 22. PMID: 37720980; PMCID: PMC10715696
Joseph Davey DL, Nyemba DC, Mvududu R, Mashele N, Johnson L, Bekker LG, Dean SS, Bheemraj K, Coates TJ, Myer L. Pregnancy outcomes following self-reported and objective-measured exposure to oral preexposure prophylaxis in South Africa. AIDS. 2024 Jan 1;38(1):75-83. doi: 10.1097/QAD.0000000000003729. Epub 2023 Nov 22.PMID: 37720980 Free PMC article.
Kamenshchikova A, Peters CMM, Nöstlinger C, Rice B, Ford N, Ravasi G, Burns F, Parczewski M, Hoebe CJPA, Dukers N, Seedat F, Mozalevskis A, Bekker LG, Berchmans Tugirimana J, Tang W, Marley G, Onyango D, Thormann Peynado MC, Noori T, Hargreaves S. Interventions to ensure access to and continuity of HIV care for international migrants: an evidence synthesis. Lancet HIV. 2024 Dec;11(12):e873-e884. doi: 10.1016/S2352-3018(24)00175-9. Epub 2024 Nov 10. PMID: 39536773.
Kamkuemah M, Gausi B, Oni T, Middelkoop K. Multilevel correlates of abdominal obesity in adolescents and youth living with HIV in periurban Cape Town, South Africa. PLoS One. 2023 Jan 24;18(1):e0266637. doi: 10.1371/journal.pone.0266637. eCollection 2023.
Kiiza D, Rostami-Hochaghan D, Alhassan Y, Seden K, Reynolds H, Kaboggoza JP, Taegtmeyer M, Chen T, Challenger E, Malaba T, Wang D, Else L, Hern F, Sharp J, Neary M, Dilly Penchala S, Waitt C, Orrell C, Colbers A, Myer L, Owen A, Rannard S, Khoo S, Lamorde M. Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa. J Antimicrob Chemother. 2024 Jul 13:dkae232. doi: 10.1093/jac/dkae232. Epub ahead of print. PMID: 38997229.
Kiiza D, Rostami-Hochaghan D, Alhassan Y, Seden K, Reynolds H, Kaboggoza JP, Taegtmeyer M, Chen T, Challenger E, Malaba T, Wang D, Else L, Hern F, Sharp J, Neary M, Dilly Penchala S, Waitt C, Orrell C, Colbers A, Myer L, Owen A, Rannard S, Khoo S, Lamorde M. Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa. J Antimicrob Chemother. 2024 Sep 3;79(9):2334-2342. doi: 10.1093/jac/dkae232. PMID: 38997229.
Killian C, West RL, Orrell C, Gifford A, Haberer JE, Halim N, Jennings L, Berkowitz N, Fourie S, Sabin L. Negative clinic experiences as a barrier to care for people with HIV and their impact on patient preferences for intervention support: a qualitative study in Cape Town, South Africa. AIDS Care. 2024 Apr 27:1-10. doi: 10.1080/09540121.2024.2346255. Epub ahead of print. PMID: 38676915.
Krogstad Mudzingwa E, de Vos L, Atujuna M, Fynn L, Mugore M, Mabandla S, Hosek S, Celum C, Bekker LG, Daniels J, Medina-Marino A. High study participation but diverging adherence levels: qualitatively unpacking PrEP use among adolescent girls and young women over two years in Eastern Cape, South Africa. J Behav Med. 2024 Apr;47(2):320-333. doi: 10.1007/s10865-023-00462-2. Epub 2023 Dec 11. PMID: 38081955; PMCID: PMC10944421.
Lambarey H, Blumenthal MJ, Chetram A, Joyimbana W, Jennings L, Orrell C, Schäfer G. Reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients. Ebiomedicine. 2024 Feb 1;100
Lambarey H, Blumenthal MJ, Chetram A, Joyimbana W, Jennings L, Orrell C, Schäfer G. Reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients. EBioMedicine. 2024 Feb;100:104986. doi: 10.1016/j.ebiom.2024.104986. Epub 2024 Feb 2. PMID: 38306893; PMCID: PMC10850403.
Landovitz RJ, Tao L, Yang J, et al. HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies. Clin Infect Dis. Published online March 14, 2024. doi:10.1093/cid/ciae143
Lemos MP, Astronomo RD, Huang Y, Narpala S, Prabhakaran M, Mann P, Paez CA, Lu Y, Mize GJ, Glantz H, Westerberg K, Colegrove H, Smythe KS, Lin M, Pierce RH, Hutter J, Frank I, Mascola JR, McDermott AB, Bekker LG, McElrath MJ. Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa. Nat Commun. 2024 Nov 28;15(1):10332. doi: 10.1038/s41467-024-54580-9. PMID: 39609400; PMCID: PMC11604655.
Levison JH, Orrell C. Can resistance testing improve outcomes for children and adolescents with HIV? Lancet Glob Health. 2024 Aug;12(8):e1219-e1220. doi: 10.1016/S2214-109X(24)00262-6. PMID: 39030053.
Magaret CA, Li L, deCamp AC, et al. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nat Commun. 2024;15(1):2175. Published 2024 Mar 11. doi:10.1038/s41467-024-46536-w
Magaret CA, Li L, deCamp AC, Rolland M, Juraska M, Williamson BD, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Heng F, Sun Y, Carpp LN, Bai H, Dearlove BL, Giorgi EE, Jongeneelen M, Brandenburg B, McCallum M, Bowen JE, Veesler D, Sadoff J, Gray GE, Roels S, Vandebosch A, Stieh DJ, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert PA, de Sousa LP, Silva MST, Casapia M, Losso MH, Little SJ, Gaur A, Bekker LG, Garrett N, Truyers C, Van Dromme I, Swann E, Marovich MA, Follmann D, Neuzil KM, Corey L, Greninger AL, Roychoudhury P, Hyrien O, Gilbert PB. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nat Commun. 2024 Mar 11;15(1):2175. doi: 10.1038/s41467-024-46536-w. PMID: 38467646; PMCID: PMC10928100.
Malaba T, Henn J, Waitt C, Myer L, Khoo S, Taegtmeyer M, Orrell C; DolPHIN3 consortium. Denying access to long-acting injectable treatment for HIV: an open letter. Lancet HIV. 2024 Dec;11(12):e802. doi: 10.1016/S2352-3018(24)00305-9. PMID: 39632049.
Marrazzo J, Tao L, Becker M, Leech AA, Taylor AW, Ussery F, Kiragu M, Reza-Paul S, Myers J, Bekker LG, Yang J, Carter C, de Boer M, Das M, Baeten JM, Celum C. HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women. JAMA. 2024 Mar 19;331(11):930-937. doi: 10.1001/jama.2024.0464. PMID: 38427359; PMCID: PMC10951736.
Marrazzo J, Tao L, Becker M, Leech AA, Taylor AW, Ussery F, Kiragu M, Reza-Paul S, Myers J, Bekker LG, Yang J, Carter C, de Boer M, Das M, Baeten JM, Celum C HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women. JAMA. 2024 Mar 1. doi: 10.1001/jama.2024.0464. Online ahead of print.PMID: 38427359
Marzinke MA, Han K, Hanscom B, Guo X, Piwowar-Manning E, Hendrix CW, Rose S, Spooner E, Mathew C, Innes S, Sekabira R, Mutambanengwe M, Rooney JF, Rinehart AR, Adeyeye A, Cohen MS, Hosseinipour M, Ford SL, Delany-Moretlwe S. Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084. Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0099424. doi: 10.1128/aac.00994-24. Epub 2024 Sep 23. PMID: 39311597; PMCID: PMC11539227.
Medina-Marino A, Bezuidenhout D, Bezuidenhout C, Facente SN, Fourie B, Shin SS, Penn-Nicholson A, Theron G. In-home TB Testing Using GeneXpert Edge is Acceptable, Feasible, and Improves the Proportion of Symptomatic Household Contacts Tested for TB: A Proof-of-Concept Study. Open Forum Infect Dis. 2024 May 13;11(6):ofae279. doi: 10.1093/ofid/ofae279. PMID: 38868309; PMCID: PMC11167660.
Medina-Marino A, Sibanda N, Putt M, Joseph Davey D, Smith P, Thirumurthy H, Bekker LG, Buttenheim A. Improving HIV testing, linkage, and retention in care among South African men through U = U messaging: A study protocol for two sequential hybrid type 1 effectiveness-implementation randomized controlled trials. PLoS One. 2024 Nov 25;19(11):e0309905. doi: 10.1371/journal.pone.0309905. PMID: 39585844; PMCID: PMC11588259.
Middelkoop K, Micklesfield L, Hemmings S, Walker N, Stewart J, Jolliffe DA, Mendham AE, Tang JCY, Cooper C, Harvey NC, Wilkinson RJ, Martineau AR. Influence of vitamin D supplementation on muscle strength and exercise capacity in South African schoolchildren: secondary outcomes from a randomised controlled trial (ViDiKids). BMJ Open Sport Exerc Med. 2024 Sep 26;10(3):e002019. doi: 10.1136/bmjsem-2024-002019. PMID: 39345832; PMCID: PMC11429360.
Middelkoop K, Micklesfield L, Stewart J, Walker N, Jolliffe DA, Mendham AE, Coussens AK, Nuttall J, Tang J, Fraser WD, Momand W, Cooper C, Harvey NC, Wilkinson RJ, Bekker LG, Martineau AR. Influence of vitamin D supplementation on growth, body composition, pubertal development and spirometry in South African schoolchildren: a randomised controlled trial (ViDiKids). BMJ Paediatr Open. 2024 Apr 10;8(1):e002495. doi: 10.1136/bmjpo-2024-002495. PMID: 38599800; PMCID: PMC11015302.
Middelkoop K, Micklesfield LK, Walker N, Stewart J, Delport C, Jolliffe DA, Mendham AE, Coussens AK, van Graan A, Nuttall J, Tang JCY, Fraser WD, Cooper C, Harvey NC, Hooper RL, Wilkinson RJ, Bekker LG, Martineau AR. Influence of vitamin D supplementation on bone mineral content, bone turnover markers, and fracture risk in South African schoolchildren: multicenter double-blind randomized placebo-controlled trial (ViDiKids). J Bone Miner Res. 2024 Apr 19;39(3):211-221. doi: 10.1093/jbmr/zjae007. PMID: 38477739; PMCID: PMC11240149.
Mkhize P, Mehou-Loko C, Maphumulo N, Radzey N, Abrahams AG, Sibeko S, Harryparsad R, Manhanzva M, Meyer B, Radebe P, Liebenberg LJP, Ngcapu S, Ahmed N, Busakwe F, Mqaba N, Archary D, Sivro A, Samsunder N, Potloane D, Horsnell W, Jordan C, Abdool Karim Q, Bekker LG, Passmore JA, Jaspan H, Humphries H, Masson L. Differences in HIV risk factors between South African adolescents and adult women and their association with sexually transmitted infections. Sex Transm Infect. 2024 Dec 4:sextrans-2024-056260. doi: 10.1136/sextrans-2024-056260. Epub ahead of print. PMID: 39632075.
Molina JM, Rizzardini G, Orrell C, Afani A, Calmy A, Oka S, Hinestrosa F, Kumar P, Tebas P, Walmsley S, Grandhi A, Klopfer S, Gendrano I, Eves K, Correll TA, Fox MC, Kim J. Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial. Lancet HIV. 2024 Jun;11(6):e369-e379. doi: 10.1016/S2352-3018(24)00031-6. Epub 2024 May 8. PMID: 38734015.
Moodie Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, Omar FL, Kee JJ, Bekker LG, Laher F, Naicker N, Jani I, Mgodi NM, Hunidzarira P, Sebe M, Miner MD, Polakowski L, Ramirez S, Nebergall M, Takuva S, Sikhosana L, Heptinstall J, Seaton KE, De Rosa S, Diazgranados CA, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, Tomaras GD, McElrath MJ, Corey L, Mngadi K, Goepfert P; HVTN 107 Protocol Team. Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial. PLoS Med. 2024 Mar 19;21(3):e1004360. doi: 10.1371/journal.pmed.1004360. PMID: 38502656; PMCID: PMC10986991.
Moolla H, Davies MA, Davies C, Euvrard J, Prozesky HW, Fox MP, Orrell C, von Groote P, Johnson LF, IeDEA Collaboration. The effect of care interruptions on mortality in adults resuming antiretroviral therapy. AIDS. 38(8): 1198-1205. 2024
Moyo P, Nyamweya D, Kubai N, Orrell C, Bekker LG. Injectable treatment for adolescents living with HIV. Lancet HIV. 2024 Dec;11(12):e800-e801. doi: 10.1016/S2352-3018(24)00265-0. Epub 2024 Oct 18. PMID: 39433047.
Mudzingwa EK, de Vos L, Fynn L, Atujuna M, Katz IT, Hosek S, Celum C, Daniels J, Bekker LG, Medina-Marino A. Youth-friendly services was the magic: Experiences of adolescent girls and young women in the community PrEP study, South Africa. Glob Public Health. 2024 Jan;19(1):2349918. doi: 10.1080/17441692.2024.2349918. Epub 2024 May 16. PMID: 38752416; PMCID: PMC11101151.
Mudzingwa EK, de Vos L, Fynn L, Atujuna M, Katz IT, Hosek S, Celum C, Daniels J, Bekker LG, Medina-Marino A. Youth-friendly services was the magic: Experiences of adolescent girls and young women in the community PrEP study, South Africa. Glob Public Health. 2024 Jan;19(1):2349918. doi: 10.1080/17441692.2024.2349918. Epub 2024 May 16. PMID: 38752416; PMCID: PMC11101151.
Naicker V, Laher F, Bekker LG, Seaton KE, Allen M, De Rosa S, Yates NL, Mkhize NN, Saunders K, Heptinstall J, Malahleha M, Mngadi K, Daniels B, Innes C, Yu C, Modise T, Bekker V, Grunenberg N, Furch B, Miner MD, Phogat S, Diazgranados CA, Gurunathan S, Koutsoukos M, Van Der Meeren O, Roxby AC, Ferrari G, Morris L, Montefiori D, McElrath MJ, Tomaras GD, Moodie Z. Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trial. PLOS Glob Public Health. 2024 Sep 20;4(9):e0003319. doi: 10.1371/journal.pgph.0003319. PMID: 39302924; PMCID: PMC11414935.
Nightingale S, Cinque P, Dravid A, Dreyer AJ, Gisslén M, Joska JA, Kwasa J, Meyer AC, Mpongo N, Nakasujja N, Pebody R, Pozniak A, Price RW, Saylor D, Thomas KGF, Underwood J, Vera JH, Winston A. Reply to ‘Cognitive criteria in HIV: greater consensus is needed’. Nat Rev Neurol. 2024 Feb;20(2):129-130. doi: 10.1038/s41582-024-00928-0. PMID: 38228907.
Nkosi T, Mulopo C, Schmidt BM. Perceptions, experiences, and motivation of COVID-19 vaccine trial participants in South Africa: a qualitative study. Res Integr Peer Rev. 2024 Jul 29;9(1):8. doi: 10.1186/s41073-024-00148-6. PMID: 39069626; PMCID: PMC11285467.
Nyakato P, Boulle A, Wood R, Eley B, Rabie H, Egger M, Yiannoutsos CT, Davies MA, Cornell M. Self-transfers, Hospital Admissions and Mortality Among Children and Adolescents Lost to Follow-up From Antiretroviral Therapy Programs in the Western Cape, South Africa Between 2004 and 2019: Linkage to Provincial Records. Pediatr Infect Dis J. 2024 May 1;43(5):430-436. doi: 10.1097/INF.0000000000004281. Epub 2024 Feb 21. PMID: 38451913.
Nyakato P, Schomaker M, Boulle A, Euvrard J, Wood R, Eley B, Prozesky H, Christ B, Anderegg N, Ayakaka I, Rafael I, Kunzekwenyika C, Moore CB, van Lettow M, Chimbetete C, Mbewe S, Ballif M, Egger M, Yiannoutsos CT, Cornell M, Davies MA. Correcting mortality estimates among children and youth on antiretroviral therapy in southern Africa: A comparative analysis between a multi-country tracing study and linkage to a health information exchange. Trop Med Int Health. 2024 Aug;29(8):739-751. doi: 10.1111/tmi.14030. Epub 2024 Jul 4. PMID: 38961819.
Owuor S, Kimani M, Kaplan R. The future of PrEP: novel long-acting HIV prevention agents for adolescent women. Pan Afr Med J. 2024 Mar 4;47:102. doi: 10.11604/pamj.2024.47.102.36052. PMID: 38766564; PMCID: PMC11101307.
Papot E, Tovar-Sanchez T, Woods J, Thaurignac G, Eriobu N, Borok M, Kaplan R, Avihingsanon A, Azwa I, Grinsztejng B, Kumarasamy N, Sokhela S, Mpoudi-Etame M, Arriaga M, Jacoby S, Matthews GV, Losso MH, Khoo S, Calmy A, Kouanfack C, Ayouba A, Petoumenos K, Venter WDF, Delaporte E, Polizzotto MN; COHIVE study group (COHIVE consortium includes ADVANCE, DolPHIN2, D2EFT and NAMSAL study groups). SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa. AIDS. 2024 Nov 22. doi: 10.1097/QAD.0000000000004068. Epub ahead of print. PMID: 39576151.
Passmore JS, Ngcapu S, Gitome S, Kullin BR, Welp K, Martin DP, Potloane D, Manhanzva MT, Obimbo MM, Gill K, Fevre ML, Happel AU, Jaspan HB, Kasaro M, Bukusi EA. Ecology meets reproductive medicine in HIV prevention: the case for geography-informed approaches for bacterial vaginosis in Africa. Front Reprod Health. 2024 Nov 27;6:1431306. doi: 10.3389/frph.2024.1431306. PMID: 39665036; PMCID: PMC11631894.
Peter J, Takalani A, Meyer JC, Semete-Makokotlela B, Collie S, Seocharan I, Goga A, Garrett N, Gail-Bekker L, Gray G. Vaccine pharmacovigilance in South Africa: successes and limitations of current approaches. Expert Opin Drug Saf. 2024 Oct;23(10):1215-1225. doi: 10.1080/14740338.2024.2387322. Epub 2024 Sep 24. PMID: 39115010.
Peters RPH, Nel JS, Sadiq E, Kufa T, Smit DP, Sorour G, Garrett N, Gill K, Makhakhe L, Chandiwana NC, Moran NF, Cohen K, Wattrus C, Moosa MY. Southern African HIV Clinicians Society Guideline for the clinical management of syphilis. South Afr J HIV Med. 2024 Apr 30;25(1):1577. doi: 10.4102/sajhivmed.v25i1.1577. PMID: 38725703; PMCID: PMC11079416.
Prudden HJ, Tatoud R, Janes H, Wallace S, Miller V, Bekker LG, Donnell D. Perspectives on Design Approaches for HIV Prevention Efficacy Trials. AIDS Res Hum Retroviruses. 2024 May;40(5):301-307. doi: 10.1089/AID.2022.0150. Epub 2023 Sep 4. PMID: 37392020; PMCID: PMC11236282.
Psaros C, Goodman GR, Lee JS, Rice W, Kelley CF, Oyedele T, Coelho LE, Phanuphak N, Singh Y, Middelkoop K, Griffith S, McCauley M, Rooney J, Rinehart AR, Clark J, Go V, Sugarman J, Fields SD, Adeyeye A, Grinsztejn B, Landovitz RJ, Safren SA; HPTN 083‐02 Study Team. HPTN 083-02: factors influencing adherence to injectable PrEP and retention in an injectable PrEP study. J Int AIDS Soc. 2024 May;27(5):e26252. doi: 10.1002/jia2.26252. PMID: 38783534; PMCID: PMC11116478.
Ramboarina S, Crucitti T, Gill K, Bekker LG, Harding-Esch EM, van de Wijgert JHHM, Huynh BT, Fortas C, Harimanana A, Mayouya Gamana T, Randremanana RV, Mangahasimbola R, Dziva Chikwari C, Kranzer K, Mackworth-Young CRS, Bernays S, Thomas N, Anderson D, Tanko FR, Manhanzva M, Lurie M, Khumalo F, Sinanovic E, Honda A, Pidwell T, Francis SC, Masson L, Passmore JA. Novel point-of-care cytokine biomarker lateral flow test for the screening for sexually transmitted infections and bacterial vaginosis: study protocol of a multicentre multidisciplinary prospective observational clinical study to evaluate the performance and feasibility of the Genital InFlammation Test (GIFT). BMJ Open. 2024 May 1;14(5):e084918. doi: 10.1136/bmjopen-2024-084918. PubMed PMID: 38692732; PubMed Central PMCID: PMC11086546.
Riou C, Bhiman JN, Ganga Y, Sawry S, Ayres F, Baguma R, Balla SR, Benede N, Bernstein M, Besethi AS, Cele S, Crowther C, Dhar M, Geyer S, Gill K, Grifoni A, Hermanus T, Kaldine H, Keeton RS, Kgagudi P, Khan K, Lazarus E, Le Roux J, Lustig G, Madzivhandila M, Magugu SFJ, Makhado Z, Manamela NP, Mkhize Q, Mosala P, Motlou TP, Mutavhatsindi H, Mzindle NB, Nana A, Nesamari R, Ngomti A, Nkayi AA, Nkosi TP, Omondi MA, Panchia R, Patel F, Sette A, Singh U, van Graan S, Venter EM, Walters A, Moyo-Gwete T, Richardson SI, Garrett N, Rees H, Bekker LG, Gray G, Burgers WA, Sigal A, Moore PL, Fairlie L. Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants. PLOS Glob Public Health. 2024 Apr 11;4(4):e0002703. doi: 10.1371/journal.pgph.0002703. PMID: 38603677; PMCID: PMC11008839.
Rose PC, Davies C, Cotton MF, Otwombe K, Browne SH, Vaida F, Innes S, Nel ER. Longitudinal controlled attenuation parameter and liver stiffness in children with and without perinatal HIV infection in South Africa. AIDS. 2024 Sep 1;38(11):1638-1647. doi: 10.1097/QAD.0000000000003964. Epub 2024 Jun 20. PMID: 38905492.
Rosen LV, Thielking AM, Dugdale CM, Montepiedra G, Kalk E, Kim S, LaCourse SM, Mathad JS, Freedberg KA, Horsburgh CR, Paltiel AD, Wood R, Ciaranello AL, Reddy KP. Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks. Clin Infect Dis. 2024 Nov 15:ciae508. doi: 10.1093/cid/ciae508. Epub ahead of print. PMID: 39544107.
Rosenberg NE, Shook-Sa BE, Young AM, et al. An HIV-1 risk assessment tool for women aged 15-49 in African countries: A pooled analysis across 15 nationally representative surveys. Clin Infect Dis. Published online April 24, 2024. doi:10.1093/cid/ciae211
Rousseau E, Bennin F, Bekker LG. Effective preexposure prophylaxis in young women and girls, a key population for HIV prevention. Curr Opin HIV AIDS. 2024 Nov 1;19(6):287-292. doi: 10.1097/COH.0000000000000885. Epub 2024 Aug 26. PMID: 39514784.
Rousseau E, Sikkema KJ, Julies RF, et al. Exploring adolescent girls and young women’s PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa. J Int AIDS Soc. 2024;27(5):e26254. doi:10.1002/jia2.26254
Sandfort TGM, Kreniske P, Mbeda C, Reynolds D, Tshabalala G, Madiwati B, Ogendo A, Dominquez K, Panchia R, Gondwe D, Hamilton EL, Guo X, Cummings V. Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075. AIDS Behav. 2024 Jul;28(7):2361-2377. doi: 10.1007/s10461-024-04334-x. Epub 2024 May 18. PMID: 38761334; PMCID: PMC11199096.
Shapley-Quinn MK, Tenza S, Jensen D, Tauya T, Mampuru L, Etima J, Kemigisha D, Atujuna M, Soto-Torres L, Johnson S, Mpongo N, Mhlanga N, Ngure K, van der Straten A. Adolescent Girls and Young Women Overcoming Adherence Challenges with Vaginal and Oral PrEP Use: A Longitudinal Qualitative Study from a Crossover Trial in South Africa, Uganda, and Zimbabwe. AIDS Behav. 2024 Dec;28(12):4209-4223. doi: 10.1007/s10461-024-04503-y. Epub 2024 Sep 30. PMID: 39343865; PMCID: PMC11586305.
Sherman A, Tuan J, Cantos VD, Adeyiga O, Mahoney S, Ortega-Villa AM, Tillman A, Whitaker J, Woodward Davis AS, Leav B, Hirsch I, Sadoff J, Dunkle LM, Gilbert PB, Janes HE, Kublin JG, Goepfert PA, Kotloff K, Rouphael N, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Nason M, Baden LR, Gay CL. COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials. Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093/cid/ciae192. Epub ahead of print. PMID: 38598658.
Smith P, Little F, Hermans S, Davies MA, Wood R, Orrell C, Pike C, Peters F, Dube A, Georgeu-Pepper D, Curran R, Fairall L, Bekker LG. A prospective randomised controlled trial investigating household SARS-CoV-2 transmission in a densely populated community in Cape Town, South Africa – the transmission of COVID-19 in crowded environments (TRACE) study. BMC Public Health. 2024 Jul 17;24(1):1924. doi: 10.1186/s12889-024-19462-1. PMID: 39020307; PMCID: PMC11256445.
Smith PJ, Thirumurthy H. Incentivising engagement in care among people with HIV. Lancet HIV. 2024 Aug 1:S2352-3018(24)00205-4. doi: 10.1016/S2352-3018(24)00205-4. Epub ahead of print. PMID: 39098326.
Stalter RM, Dong TQ, Hendrix CW, Palanee-Phillips T, van der Straten A, Hillier SL, Kiweewa FM, Mgodi NM, Marzinke MA, Bekker LG, Soto-Torres L, Baeten JM, Brown ER; MTN-020/ASPIRE Study Team. Assessing Per-Sex-Act HIV-1 Risk Reduction Among Women Using the Dapivirine Vaginal Ring. J Infect Dis. 2024 Apr 12;229(4):1158-1165. doi: 10.1093/infdis/jiad550. PMID: 38099506; PMCID: PMC11011174.
Stewart J, Walker N, Jennings K, Delport C, Nuttall J, Coussens AK, Dyers R, Jolliffe DA, Tang JCY, Fraser WD, Wilkinson RJ, Bekker LG, Martineau AR, Middelkoop K. Prevalence, incidence and determinants of QuantiFERONTM positivity in South African schoolchildren. IJTLD Open. 2024 May 1;1(5):206-214. doi: 10.5588/ijtldopen.24.0084. PMID: 39022781; PMCID: PMC11249604.
Stockton MA, Mazinyo EW, Mlanjeni L, Sweetland AC, Scharf JY, Nogemane K, Ngcelwane N, Basaraba C, Bezuidenhout C, Sansbury G, Olivier D, Grobler C, Wall MM, Medina-Marino A, Nobatyi P, Wainberg ML. Validation of screening instruments for common mental disorders and suicide risk in south African primary care settings. J Affect Disord. 2024 Oct 1;362:161-168. doi: 10.1016/j.jad.2024.06.071. Epub 2024 Jun 20. PMID: 38908555; PMCID: PMC11316636.
Takalani A, Robinson M, Jonas P, Bodenstein A, Sambo V, Jacobson B, Louw V, Opie J, Peter J, Rowji P, Seocharan I, Reddy T, Yende-Zuma N, Khutho K, Sanne I, Bekker LG, Gray G, Garrett N, Goga A; Sisonke Study Team. Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa. Vaccine. 2024 Feb 27;42(6):1195-1199. doi: 10.1016/j.vaccine.2024.01.066. Epub 2024 Jan 25. PMID: 38278629.
Tembo TA, Mollan K, Simon K, Rutstein S, Chitani MJ, Saha PT, Mbeya-Munkhondya T, Jean-Baptiste M, Meek C, Mwapasa V, Go V, Bekker LG, Kim MH, Rosenberg NE. Does a blended learning implementation package enhance HIV index case testing in Malawi? A protocol for a cluster randomised controlled trial. BMJ Open. 2024 Jan 22;14(1):e077706. doi: 10.1136/bmjopen-2023-077706.PMID: 38253452 Free PMC article.
Van Zyl GU, Jennings L, Rabie H, Orrell C. Dolutegravir regimens have transformed treatment but ongoing drug resistance research is required to maintain success. AIDS. 2024 Dec 23. doi: 10.1097/QAD.0000000000004099. Epub ahead of print. PMID: 39715045.
Venter WDF, Gandhi M, Sokhela S, Sikwese K, Bygrave H, Gama LD, Mphothulo N, Jamieson L, Siedner MJ, Pozniak AL, Rojo P, Baptiste SL, Wambui J, Meyer-Rath G, Honermann B, Warren M, Bekker LG, Sinxadi P, Collins S, Burry J, Möller K, Clayden P, Owen A, Hill A. The long wait for long-acting HIV prevention and treatment formulations. Lancet HIV. 2024 Oct;11(10):e711-e716. doi: 10.1016/S2352-3018(24)00173-5. Epub 2024 Aug 16. Erratum in: Lancet HIV. 2024 Dec;11(12):e804. doi: 10.1016/S2352-3018(24)00232-7. PMID: 39159655.
Wechsberg WM, Carney T, Browne FA, van der Drift IM, Kline TL, Nyblade LL, Ndirangu J, Orrell C, Bonner CP, Caron E. Multilevel strategies to end HIV for young couples in Cape Town: Study protocol for a cluster randomized trial. Plos One. June 7, 2024

2023

Ahmed N, Pike C, Lee J, Wagner C, Bekker LG. School-based healthcare services in Cape Town, South Africa: When there’s a will, there’s a way. Afr J Prim Health Care Fam Med. 2023 Oct 27;15(1):e1-e3. doi: 10.4102/phcfm.v15i1.4216. PMID: 37916715; PMCID: PMC10623473.
Asare K, Andine T, Naicker N, Dorward J, Singh N, Spooner E, Andriesen J, Osman F, Ngcapu S, Vandormael A, Mindel A, Abdool Karim SS, Bekker LG, Gray G, Corey L, Tomita A, Garrett N. Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial. Clin Infect Dis. 2023 Mar 4;76(5):881-889. doi: 10.1093/cid/ciac824. Erratum in: Clin Infect Dis. 2023 Jan 6;76(1):182. doi: 10.1093/cid/ciac898. PMID: 36250382; PMCID: PMC7614294.
Atujuna M, Tucker J, Crooks N, Zanoni B, Donenberg GR. Disseminating Evidence-Based Interventions for Adolescent HIV Treatment and Prevention in Sub-Saharan Africa. AIDS Behav. 2023 May;27(Suppl 1):64-72. doi: 10.1007/s10461-022-03794-3. Epub 2022 Sep 27. PMID: 36166109; PMCID: PMC9514160.
Babalola CM, Peters RPH, Mukomana F, Mdingi M, Gigi RMS, Muzny CA, Taylor CM, Medina-Marino A, Klausner JD. A Call to Standardize the Definition and Method of Assessing Women for Vaginal Discharge Syndrome in Pregnancy. Open Forum Infect Dis. 2023 Mar 22;10(4):ofad157. doi: 10.1093/ofid/ofad157. PMID: 37035494; PMCID: PMC10077826.
Basaraba CN, Stockton MA, Sweetland A, Medina-Marino A, Lovero KL, Oquendo MA, Greene MC, Mocumbi AO, Gouveia L, Mello M, Dos Santos P, Suleman A, Mabunda D, Mandlate F, Xavier A, Fumo W, Massinga L, Khan S, Feliciano P, Kann B, Salem AF, Bezuidenhout C, Mootz JJ, Duarte CS, Cournos F, Wall MM, Wainberg ML. Does It Matter What Screener We Use? A Comparison of Ultra-brief PHQ-4 and E-mwTool-3 Screeners for Anxiety and Depression Among People With and Without HIV. AIDS Behav. 2023 Apr;27(4):1154-1161. doi: 10.1007/s10461-022-03852-w. Epub 2022 Oct 8. PMID: 36209180; PMCID: PMC10125788.
Beauchamp G, Donnell D, Hosek S, Anderson PL, Chan KCG, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C. Trust in the provider and accurate self-reported PrEP adherence among adolescent girls and young women in South Africa and Zimbabwe: HPTN 082 study. BMC Womens Health. 2023 May 19;23(1):276. doi: 10.1186/s12905-023-02418-9. PMID: 37208687; PMCID: PMC10199602.
Beauchamp G, Hosek S, Donnell D, Chan KCG, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C; HPTN 082 study team. The Effect of Disclosure of PrEP Use on Adherence Among African Young Women in an Open-Label PrEP Study: Findings from HPTN 082. AIDS Behav. 2024 May;28(5):1512-1521. doi: 10.1007/s10461-023-04175-0. Epub 2023 Sep 28. PMID: 37768427; PMCID: PMC11069481.
Beauchamp G, Hosek S, Donnell DJ, Chan KCG, Flaherty BP, Anderson PL, Dye BJ, Mgodi N, Bekker LG, Delany-Moretlwe S, Celum C; HPTN 082 study team. Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study. PLoS One. 2023 Feb 24;18(2):e0281728. doi: 10.1371/journal.pone.0281728. PMID: 36827440; PMCID: PMC9956790.
Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, Masters MC, Lazarus JV. HIV infection. Nat Rev Dis Primers. 2023 Aug 17;9(1):42. doi: 10.1038/s41572-023-00452-3. Erratum in: Nat Rev Dis Primers. 2023 Sep 11;9(1):48. doi: 10.1038/s41572-023-00464-z. PMID: 37591865.
Bekker LG, Smith P, Ntusi NAB. HIV is sexually untransmittable when viral load is undetectable. Lancet. 2023 Aug 5;402(10400):428-429. doi: 10.1016/S0140-6736(23)01519-2. Epub 2023 Jul 22. PMID: 37490934.
Bekker LG. The HIV epidemic 40 years on. Nat Rev Microbiol. 2023 Dec;21(12):767-768. doi: 10.1038/s41579-023-00979-y. PMID: 37814111.
Bhiman JN, Richardson SI, Lambson BE, Kgagudi P, Mzindle N, Kaldine H, Crowther C, Gray G, Bekker LG; Novavax trial clinical lead author group; Shinde V, Bennett C, Glenn GM, Madhi SA, Moore PL. Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages. Sci Rep. 2023 Jan 21;13(1):1222. doi: 10.1038/s41598-023-27698-x. PMID: 36681693; PMCID: PMC9867547.
Brittain K, Gomba Y, Noholoza S, Pellowski J, Mellins CA, Bekker LG, Kagee A, Remien RH, Abrams EJ, Myer L. HIV-related stigma, disclosure and social support: experiences among young pregnant and postpartum women living with HIV in South Africa. AIDS Care. 2023 Mar;35(3):399-405. doi: 10.1080/09540121.2022.2121957. Epub 2022 Sep 14. PMID: 36102063; PMCID: PMC10011013.
Brown LK, Van Schalkwyk C, De Villiers AK, Marx FM. Impact of interventions for tuberculosis prevention and care in South Africa – a systematic review of mathematical modelling studies. S Afr Med J. 2023 Mar 2;113(3):125-134. doi: 10.7196/SAMJ.2023.v113i3.16812. PMID: 36876352.
Cable J, Graham BS, Koup RA, Seder RA, Karikó K, Pardi N, Barouch DH, Sharma B, Rauch S, Nachbagauer R, Forsell MNE, Schotsaert M, Ellebedy AH, Loré K, Irvine DJ, Pilkington E, Tahtinen S, Thompson EA, Feraoun Y, King NP, Saunders K, Alter G, Moin SM, Sliepen K, Karlsson Hedestam GB, Wardemann H, Pulendran B, Doria-Rose NA, He WT, Juno JA, Ataca S, Wheatley AK, McLellan JS, Walker LM, Lederhofer J, Lindesmith LC, Wille H, Hotez PJ, Bekker LG. Progress in vaccine development for infectious diseases-a Keystone Symposia report. Ann N Y Acad Sci. 2023 Jun;1524(1):65-86. doi: 10.1111/nyas.14975. Epub 2023 Apr 5. PMID: 37020354.
Daniels J, De Vos L, Bezuidenhout D, Atujuna M, Celum C, Hosek S, Bekker LG, Medina-Marino A. “I know why I am taking this pill”: Young women navigation of disclosure and support for PrEP uptake and adherence in Eastern Cape Province, South Africa. PLOS Glob Public Health. 2023 Jan 20;3(1):e0000636. doi: 10.1371/journal.pgph.0000636. PMID: 36962727; PMCID: PMC10021316.
Daniels J, Peters RPH, Portle S, Mashabela N, Struthers H, Radebe O, Nel D, Medina-Marino A, Bongo C, Stephenson R. Developing the Speaking Out and Allying Relationships Intervention on Videoconference for HIV-Positive GBMSM in Eastern Cape, South Africa. Am J Mens Health. 2023 Sep-Oct;17(5):15579883231197355. doi: 10.1177/15579883231197355. PMID: 37675590; PMCID: PMC10486223.
Davies C, Vaida F, Otwombe K, Cotton MF, Browne S, Innes S. Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa. AIDS. 2023 Mar 1;37(3):523-533. doi: 10.1097/QAD.0000000000003452. Epub 2022 Dec 2. PMID: 36695362; PMCID: PMC9883048.
Davies C, Vaida F, Otwombe K, Cotton MF, Browne SH, Innes S. Pulse wave velocity in early-treated children living with perinatal HIV infection is similar to uninfected children. AIDS. 2023 Jun 1;37(7):1115-1123. doi: 10.1097/QAD.0000000000003525. Epub 2023 Feb 16. PMID: 36928069; PMCID: PMC10164068.
de Vos L, Mudzingwa EK, Fynn L, Atujuna M, Mugore M, Gandhi M, Celum C, Hosek S, Bekker LG, Daniels J, Medina-Marino A. Factors that influence adolescent girls and young women’s re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa. J Int AIDS Soc. 2023 Sep;26(9):e26175. doi: 10.1002/jia2.26175. PMID: 37758649; PMCID: PMC10533377.
Delany-Moretlwe S, Mgodi N, Bekker LG, Baeten JM, Li C, Donnell D, Agyei Y, Lennon D, Rose SM, Mokgatle M, Kassim S, Mukaka S, Adeyeye A, Celum C. High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial. Sex Transm Infect. 2023 Nov;99(7):433-439. doi: 10.1136/sextrans-2022-055696. Epub 2023 Mar 8. PMID: 36889914; PMCID: PMC10555488.
Dietrich JJ, Ahmed N, Tshabalala G, Wu M, Mulaudzi M, Hornschuh S, Atujuna M, Muhumuza R, Ssemata AS, Stranix-Chibanda L, Nematadzira T, Bekker LG, Martinson N, Seeley J, Fox J. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe. PLoS One. 2023 Jun 29;18(6):e0287627. doi: 10.1371/journal.pone.0287627. PMID: 37384792; PMCID: PMC10310032.
Donnell D, Gao F, Hughes JP, Hanscom B, Corey L, Cohen MS, Edupuganti S, Mgodi N, Rees H, Baeten JM, Gray G, Bekker LG, Hosseinipour M, Delany-Moretlwe S. Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women. J Int AIDS Soc. 2023 Jun;26(6):e26118. doi: 10.1002/jia2.26118. PMID: 37363917; PMCID: PMC10292682.
Ferraris CM, D’avanzo PA, Jennings L, Robbins RN, Nguyen N, Leu CS, Dolezal C, Mgbako O, Hsiao NY, Joska J, Castillo-Mancilla JR, Myer L, Anderson PL, Belaunzarán-Zamudio PF, Mellins CA, Orrell C, Remien RH. Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa. AIDS Behav. 2023 Oct;27(10):3478-3486. doi: 10.1007/s10461-023-04063-7. Epub 2023 Apr 12. PMID: 37043053; PMCID: PMC10811583.
Foster I, Biewer A, Vanqa N, Makanda G, Tisile P, Hayward SE, Wademan DT, Anthony MG, Mbuyamba R, Galloway M, Human W, Westhuizen HM, Friedland JS, Marino-Medina A, Schoeman I, Hoddinott G, Nathavitharana RR. “This is an illness. No one is supposed to be treated badly”: Community-based stigma assessments in South Africa to inform TB stigma intervention design. Res Sq [Preprint]. 2023 Dec 11:rs.3.rs-3716733. doi: 10.21203/rs.3.rs-3716733/v1. Update in: BMC Glob Public Health. 2024;2(1):41. doi: 10.1186/s44263-024-00070-5. PMID: 38168425; PMCID: PMC10760241.
Fynn L, Gill K, Wallace M, Atujuna M, Duyver M, Ngcobo P, Spiegel H, Rinehart A, Hosek S, Bekker LG. “It’s already in your body and it’s preventing”: a qualitative study of African female adolescent’s acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa. BMC Public Health. 2023 Nov 2;23(1):2143. doi: 10.1186/s12889-023-16955-3. PMID: 37919697; PMCID: PMC10621226.
Gafar F, Wasmann RE, McIlleron HM, Aarnoutse RE, Schaaf HS, Marais BJ, Agarwal D, Antwi S, Bang ND, Bekker A, Bell DJ, Chabala C, Choo L, Davies GR, Day JN, Dayal R, Denti P, Donald PR, Engidawork E, Garcia-Prats AJ, Gibb D, Graham SM, Hesseling AC, Heysell SK, Idris MI, Kabra SK, Kinikar A, Kumar AKH, Kwara A, Lodha R, Magis-Escurra C, Martinez N, Mathew BS, Mave V, Mduma E, Mlotha-Mitole R, Mpagama SG, Mukherjee A, Nataprawira HM, Peloquin CA, Pouplin T, Ramachandran G, Ranjalkar J, Roy V, Ruslami R, Shah I, Singh Y, Sturkenboom MGG, Svensson EM, Swaminathan S, Thatte U, Thee S, Thomas TA, Tikiso T, Touw DJ, Turkova A, Velpandian T, Verhagen LM, Winckler JL, Yang H, Yunivita V, Taxis K, Stevens J, Alffenaar JC; Global Collaborative Group for Meta-Analysis of Paediatric Individual Patient Data in Pharmacokinetics of Anti-TB Drugs. Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis. Eur Respir J. 2023 Mar 9;61(3):2201596. doi: 10.1183/13993003.01596-2022. PMID: 36328357; PMCID: PMC9996834.
Garcia M, Roberts ST, Mayo AJ, Scheckter R, Mansoor LE, Palanee-Phillips T, Reddy K, Naidoo Y, Akello CA, Gaffoor Z, Siva S, Rushwaya C, Hlahla K, Jambaya J, Makoni R, Kachale E, Ndovie M, Zuma J, Montgomery ET; MTN-025/HOPE study team. Integrating Gender-Based Violence Screening and Support into the Research Clinic Setting: Experiences from an HIV Prevention Open-Label Extension Trial in Sub-Saharan Africa. AIDS Behav. 2023 Apr;27(4):1277-1286. doi: 10.1007/s10461-022-03864-6. Epub 2022 Sep 30. PMID: 36178556; PMCID: PMC10036410.
Gie A, Davies C, Vaida F, Morrison J, Maree D, Otwombe K, Browne SH, van der Zalm MM, Cotton MF, Innes S, Goussard P. Lung function tracking in children with perinatally acquired HIV following early antiretroviral therapy initiation. Thorax. 2023 Dec;78(12):1233-1239. doi: 10.1136/thorax-2023-220197. Epub 2023 Jul 21. PMID: 37479478; PMCID: PMC10715541.
Giovenco D, Pettifor A, Bekker LG, Filiatreau LM, Liu T, Akande M, Gill K, Atujuna M, Stein DJ, Kuo C. Understanding Oral Prep Interest Among South African Adolescents: The Role of Perceived Parental Support and PrEP Stigma. AIDS Behav. 2023 Jun;27(6):1906-1913. doi: 10.1007/s10461-022-03924-x. Epub 2022 Nov 16. PMID: 36383273; PMCID: PMC10149574.
Giovenco D, Pettifor A, Itzikowitz G, Chung S, Qayiya Y, Kȧgesten AE, Ekström AM, Bekker LG. Access to sexual and reproductive health services among South African young people living with and without HIV during the COVID-19 pandemic. Contraception. 2023 Oct;126:110119. doi: 10.1016/j.contraception.2023.110119. Epub 2023 Jul 17. PMID: 37467919.
Govender K, Nyamaruze P, Cowden RG, Pillay Y, Bekker LG. Children and young women in eastern and southern Africa are key to meeting 2030 HIV targets: time to accelerate action. Lancet HIV. 2023 May;10(5):e343-e350. doi: 10.1016/S2352-3018(23)00012-7. PMID: 37149293.
Gupta PM, Balle C, Tharp GK, Nelson SA, Gasper MA, Brown B, Alisoltani A, Onono M, Palanee-Phillips T, Nair G, Ayele H, Noel-Romas L, Passmore JS, Burgener AD, Heffron R, Jaspan HB, Bosinger SE. Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD. Clin Immunol. 2023 Oct;255:109750. doi: 10.1016/j.clim.2023.109750. Epub 2023 Sep 3. PMID: 37660744; PMCID: PMC10570927.
Guzman K, Crowder R, Leddy A, Maraba N, Jennings L, Ahmed S, Sultana S, Onjare B, Shilugu L, Alacapa J, Levy J, Katamba A, Kityamuwesi A, Bogdanov A, Gamazina K, Cattamanchi A, Khan A. Acceptability and feasibility of digital adherence technologies for drug-susceptible tuberculosis treatment supervision: A meta-analysis of implementation feedback. PLOS Digit Health. 2023 Aug 15;2(8):e0000322. doi: 10.1371/journal.pdig.0000322. PMID: 37582066; PMCID: PMC10426983.
Happel AU, Balle C, Havyarimana E, Brown B, Maust BS, Feng C, Yi BH, Gill K, Bekker LG, Passmore JS, Jaspan HB, Varsani A. Cervicovaginal Human Papillomavirus Genomes, Microbiota Composition and Cytokine Concentrations in South African Adolescents. Viruses. 2023 Mar 15;15(3):758. doi: 10.3390/v15030758. PMID: 36992467; PMCID: PMC10054107.
Haribhai S, Khadka N, Mvududu R, Mashele N, Bekker LG, Gorbach P, Coates TJ, Myer L, Joseph Davey DL. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study. Int J STD AIDS. 2023 Jul;34(8):548-556. doi: 10.1177/09564624231152776. Epub 2023 Mar 22. PMID: 36947792.
Hartley F, Knight L, Humphries H, Trappler J, Gill K, Bekker LG, MacKenny V, Passmore JS. “Words are too small”: exploring artmaking as a tool to facilitate dialogues with young South African women about their sexual and reproductive health experiences. Front Reprod Health. 2023 Aug 11;5:1194158. doi: 10.3389/frph.2023.1194158. PMID: 37638128; PMCID: PMC10450937.
Hartmann M, Giovenco D, Zeebari Z, Itzikowitz G, Ekström AM, Nielsen A, Pettifor A, Bekker LG, Kågesten AE. Associations between psychosocial wellbeing and experience of gender-based violence at community, household, and intimate-partner levels among a cross-sectional cohort of young people living with and without HIV during COVID-19 in Cape Town, South Africa. BMC Public Health. 2023 Oct 27;23(1):2115. doi: 10.1186/s12889-023-16945-5. PMID: 37891509; PMCID: PMC10612288.
Herrera C, Serwanga J, Else L, Limakatso L, Opoka D, Ssemata AS, Pillay AD, Namubiru P, Seiphetlo TB, Odoch G, Mugaba S, Seatlholo P, Alieu A, Penchala SD, Muhumuza R, Alinde B, Petkov S, O’Hagan K, Callebaut C, Seeley J, Weiss H, Khoo S, Chiodi F, Gray CM, Kaleebu P, Webb EL, Martinson N, Fox J; CHAPS. Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial. EBioMedicine. 2023 Jul;93:104648. doi: 10.1016/j.ebiom.2023.104648. Epub 2023 Jun 14. PMID: 37327677; PMCID: PMC10275696.
Horak J, Venter WDF, Wattrus C, Papavarnavas N, Howell P, Sorour G, Wallis C, Gill K, Conradie F, Bekker LG. Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis: Updated recommendations. South Afr J HIV Med. 2023 Sep 28;24(1):1522. doi: 10.4102/sajhivmed.v24i1.1522. PMID: 37795431; PMCID: PMC10546897.
Hyle EP, Martey EB, Bekker LG, Xu A, Parker RA, Walensky RP, Middelkoop K. Diet, physical activity, and obesity among ART-experienced people with HIV in South Africa. AIDS Care. 2023 Jan;35(1):71-77. doi: 10.1080/09540121.2021.2012556. Epub 2021 Dec 16. PMID: 34913762; PMCID: PMC9200895.
Jacobson BF, Schapkaitz E, Takalani A, Rowji PF, Louw V, Opie J, Bekker LG, Garrett N, Goga A, Reddy T, Zuma NY, Sanne I, Seocharan I, Peter J, Robinson M, Collie S, Khan A, Takuva S, Gray G. Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study). BMJ Med. 2023 Mar 23;2(1):e000302. doi: 10.1136/bmjmed-2022-000302. PMID: 37063238; PMCID: PMC10083528.
Jennings L, Ferraris CM, Castillo-Mancilla JR, Robbins RN, Nguyen N, Leu CS, Dolezal C, Hsiao NY, Mgbako O, Joska J, Myer L, Anderson PL, Remien RH, Orrell C; ADD-ART team. Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors. J Acquir Immune Defic Syndr. 2023 Aug 1;93(4):327-332. doi: 10.1097/QAI.0000000000003198. Epub 2023 Mar 24. PMID: 36976520; PMCID: PMC10287050.
Jennings L, West RL, Halim N, Kaiser JL, Gwadz M, MacLeod WB, Gifford AL, Haberer JE, Orrell C, Sabin LL. Protocol for an evaluation of adherence monitoring and support interventions among people initiating antiretroviral therapy in Cape Town, South Africa-a multiphase optimization strategy (MOST) approach using a fractional factorial design. Trials. 2023 May 5;24(1):310. doi: 10.1186/s13063-023-07322-z. PMID: 37147725; PMCID: PMC10163747.
Jimoh AO, Balle C, Brown B, Feng C, Havyarimana E, Konstantinus IN, Gill K, Bekker LG, Passmore JS, Jaspan HB, Varsani A, Happel AU. Genome Sequences of Anelloviruses, a Genomovirus, Microviruses, Polyomaviruses, and an Unclassified Caudovirus Identified in Vaginal Secretions from South African Adolescents. Microbiol Resour Announc. 2023 Jan 24;12(1):e0114322. doi: 10.1128/mra.01143-22. Epub 2022 Dec 19. PMID: 36533922; PMCID: PMC9872636.
Jochim J, Cluver L, Sidloyi L, Kelly J, Ornellas A, Mangqalaza H, Coakley C, Nogoduka C, Pillay M, Nokama B, George G, Toska E, Eastern Cape TAG. Improving educational and reproductive outcomes for adolescent mothers in South Africa: A cross-sectional analysis towards realising policy goals. Glob Public Health. 2023 Jan;18(1):2206465. doi: 10.1080/17441692.2023.2206465. PMID: 37158293.
Jorgensen AL, Orrell C, Waitt C, Toh CH, Sekaggya-Wiltshire C, Hughes DA, Allen E, Okello E, Tatz G, Culeddu G, Asiimwe IG, Semakula JR, Mouton JP, Cohen K, Blockman M, Lamorde M, Pirmohamed M. A “Bundle of Care” to Improve Anticoagulation Control in Patients Receiving Warfarin in Uganda and South Africa: Protocol for an Implementation Study. JMIR Res Protoc. 2023 Jul 19;12:e46710. doi: 10.2196/46710. PMID: 37467034; PMCID: PMC10398551.
Joseph Davey DL, Wilkinson L, Grimsrud A, Nelson A, Gray A, Raphael Y, Wattrus C, Pillay Y, Bekker LG. Urgent appeal to allow all professional nurses and midwives to prescribe pre-exposure prophylaxis (PrEP) in South Africa. S Afr Med J. 2023 Aug 3;113(8):12-16. doi: 10.7196/SAMJ.2023.v113i8.1191. PMID: 37882113.
Kakande A, Ssemata AS, Muhumuza R, Atujuna M, Abaasa A, Ndekezi D, Tshabalala G, Nematadzira T, Hornschuh S, Nomvuyo M, Ahmed N, Maluadzi M, Anne Weiss H, Webb E, Stranix-Chibanda L, Janine Dietrich J, Seeley J, Fox J. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries. PLoS One. 2023 Oct 9;18(10):e0285132. doi: 10.1371/journal.pone.0285132. PMID: 37812644; PMCID: PMC10561834.
Kamkuemah M, Gausi B, Oni T, Middelkoop K. Multilevel correlates of abdominal obesity in adolescents and youth living with HIV in peri-urban Cape Town, South Africa PLoS One (2023) Jan 24;18(1):e0266637. doi: 10.1371/journal.pone.0266637.
Karuna S, Gallardo-Cartagena JA, Theodore D, Hunidzarira P, Montenegro-Idrogo J, Hu J, Jones M, Kim V, De La Grecca R, Trahey M, Karg C, Takalani A, Polakowski L, Hutter J, Miner MD, Erdmann N, Goepfert P, Maboa R, Corey L, Gill K, Li SS; HVTN 405/HPTN 1901 Study Team. Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region. J Glob Health. 2023 Jun 23;13:06020. doi: 10.7189/jogh.13.06020. PMID: 37352144; PMCID: PMC10289480.
Keeton R, Tincho MB, Suzuki A, Benede N, Ngomti A, Baguma R, Chauke MV, Mennen M, Skelem S, Adriaanse M, Grifoni A, Weiskopf D, Sette A, Bekker LG, Gray G, Ntusi NAB, Burgers WA, Riou C. Impact of SARS-CoV-2 exposure history on the T cell and IgG response. Cell Rep Med. 2023 Jan 17;4(1):100898. doi: 10.1016/j.xcrm.2022.100898. Epub 2022 Dec 22.PMID: 36584684
Khadka N, Gorbach PM, Nyemba DC, Mvududu R, Mashele N, Javanbakht M, Nianogo RA, Aldrovandi GM, Bekker LG, Coates TJ, Myer L, Joseph Davey DL. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa. Front Reprod Health. 2023 Sep 19;5:1224474. doi: 10.3389/frph.2023.1224474. PMID: 37795521; PMCID: PMC10546059.
Krause RGE, Moyo-Gwete T, Richardson SI, Makhado Z, Manamela NP, Hermanus T, Mkhize NN, Keeton R, Benede N, Mennen M, Skelem S, Karim F, Khan K, Riou C, Ntusi NAB, Goga A, Gray G, Hanekom W, Garrett N, Bekker LG, Groll A, Sigal A, Moore PL, Burgers WA, Leslie A. Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells. NPJ Vaccines. 2023 Aug 12;8(1):119. doi: 10.1038/s41541-023-00724-9. PMID: 37573434; PMCID: PMC10423246.
Laher F, Otwombe K, Mokwena O, Bekker LG, Allen M. Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa. AIDS Behav. 2023 Apr;27(4):1314-1320. doi: 10.1007/s10461-022-03867-3. Epub 2022 Oct 26. PMID: 36287343; PMCID: PMC10038814.
Lundgren JD, Babiker AG, Sharma S, Grund B, Phillips AN, Matthews G, Kan VL, Aagaard B, Abo I, Alston B, Arenas-Pinto A, Avihingsanon A, Badal-Faesen S, Brites C, Carey C, Casseb J, Clarke A, Collins S, Corbelli GM, Dao S, Denning ET, Emery S, Eriobu N, Florence E, Furrer H, Fätkenheuer G, Gerstoft J, Gisslén M, Goodall K, Henry K, Horban A, Hoy J, Hudson F, Azwa RISR, Kedem E, Kelleher A, Kityo C, Klingman K, Rosa A, Leturque N, Lifson AR, Losso M, Lutaakome J, Madero JS, Mallon P, Mansinho K, Filali KME, Molina JM, Murray DD, Nagalingeswaran K, Nozza S, Ormaasen V, Paredes R, Peireira LC, Pillay S, Polizzotto MN, Raben D, Rieger A, Sanchez A, Schechter M, Sedlacek D, Staub T, Touloumi G, Turner M, Madruga JV, Vjecha M, Wolff M, Wood R, Zilmer K, Lane HC, Neaton JD; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group. Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. NEJM Evid. 2023 Mar;2(3):10.1056/evidoa2200302. doi: 10.1056/evidoa2200302. Epub 2023 Feb 27. PMID: 37213438; PMCID: PMC10194271.
MacDonald DM, Samorodnitsky S, Wendt CH, Baker JV, Collins G, Kruk M, Lock EF, Paredes R, Poongulali S, Weise DO, Winston A, Wood R, Kunisaki KM; INSIGHT START Pulmonary Substudy Group. Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV. Sci Rep. 2023 Mar 23;13(1):4749. doi: 10.1038/s41598-023-29739-x. PMID: 36959289; PMCID: PMC10036615.
Magaret C, Li L, deCamp A, Rolland M, Juraska M, Williamson B, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Carpp L, Bai H, Deariove B, Greninger A, Roychoudhury P, Sadoff J, Gray G, Roels S, Vandebosch A, Stieh D, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert P, Truyers C, Van Dromme I, Swann E, Marovich M, Follmann D, Neuzil K, Corey L, Hyrien O, Paiva de Sousa L, Casapia M, Losso M, Little S, Gaur A, Bekker LG, Garrett N, Heng F, Sun Y, Gilbert P. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Res Sq [Preprint]. 2023 May 31:rs.3.rs-2743022. doi: 10.21203/rs.3.rs-2743022/v1. Update in: Nat Commun. 2024 Mar 11;15(1):2175. doi: 10.1038/s41467-024-46536-w. PMID: 37398105; PMCID: PMC10312950.
Malahleha M, Laher F, Dilraj A, Smith P, Gray GE, Grove D, Odhiambo JA, Andrasik MP, Grunenberg NA, Moodie Z, Huang Y, Borate BR, Gillespie KM, Allen M, Atujuna M, Singh N, Kalonji D, Meintjes G, Kotze P, Bekker LG, Janes H. Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa. AIDS Behav. 2023 Sep;27(9):3027-3037. doi: 10.1007/s10461-023-04025-z. Epub 2023 Mar 16. PMID: 36929319; PMCID: PMC10386918.
Malo VF, Ritchwood TD, Hart LJ, Atujuna M. A qualitative analysis of family support for adolescent HIV care in South Africa. AIDS Care. 2023 Mar;35(3):425-430. doi: 10.1080/09540121.2022.2121956. Epub 2022 Sep 17. PMID: 36120906; PMCID: PMC10020124.
Mancuso N, Mathebula F, Chitukuta M, Matambanadzo KV, Tenza S, Reddy K, Nobula L, Kemigisha D, Stoner MCD. The impact of COVID-19 on sexual behavior, HIV prevention interest, general healthcare access, and other HIV risk factors among trial participants in Malawi, South Africa, Uganda, and Zimbabwe. Front Reprod Health. 2023 Oct 30;5:1270419. doi: 10.3389/frph.2023.1270419. PMID: 37965588; PMCID: PMC10642282.
Marcus R, C P, Gill K, Smith P, Rouhani S, Mendelsohn A, Mendel E, Lince-Deroche N, Naidoo K, Ahmed N, Stirrup O, Roseleur J, Leuner R, Meyer-Rath G, Bekker LG. Acceptability, feasibility and cost of point of care testing for sexually transmitted infections among South African adolescents where syndromic management is standard of care. BMC Health Serv Res. 2023 Oct 10;23(1):1078. doi: 10.1186/s12913-023-10068-8. PMID: 37817160; PMCID: PMC10566254.
Marzinke MA, Hanscom B, Wang Z, Safren SA, Psaros C, Donnell D, Richardson PA, Sullivan P, Eshleman SH, Jennings A, Feliciano KG, Jalil E, Coutinho C, Cardozo N, Maia B, Khan T, Singh Y, Middelkoop K, Franks J, Valencia J, Sanchez N, Lucas J, Rooney JF, Rinehart AR, Ford S, Adeyeye A, Cohen MS, McCauley M, Landovitz RJ, Grinsztejn B; HPTN 083 study group. Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial. Lancet HIV. 2023 Nov;10(11):e703-e712. doi: 10.1016/S2352-3018(23)00200-X. Epub 2023 Sep 29. PMID: 37783219; PMCID: PMC10842527.
Mashingaidze R, Moodie Z, Allen M, Bekker LG, Grove D, Grunenberg N, Huang Y, Janes HE, Lazarus EM, Malahleha M, Nchabeleng M, Laher F. Sexually transmitted infections amongst men who have sex with men (MSM) in South Africa. PLOS Glob Public Health. 2023 Apr 5;3(4):e0001782. doi: 10.1371/journal.pgph.0001782. PMID: 37018240; PMCID: PMC10075439.
Mcinziba A, Wademan D, Viljoen L, Myburgh H, Jennings L, Decloedt E, Orrell C, van Zyl G, van Schalkwyk M, Gandhi M, Hoddinott G. Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability. AIDS Care. 2023 Oct;35(10):1628-1634. doi: 10.1080/09540121.2023.2174928. Epub 2023 Feb 13. PMID: 36781407; PMCID: PMC10423296.
Mdingi MM, Peters RPH, Gigi R, Babalola C, Taylor CM, Muzny CA, Low N, Medina-Marino A, Klausner JD. Same-Day Treatment Following Point-of-Care Sexually Transmitted Infection Testing in Different Healthcare Settings in South Africa. Clin Infect Dis. 2023 May 3;76(9):1699-1700. doi: 10.1093/cid/ciac974. PMID: 36573007; PMCID: PMC10411922.
Medina-Marino A, Sibanda N, Putt M, Joseph Davey D, Smith P, Thirumurthy H, Bekker LG, Buttenheim A. Improving HIV testing, linkage, and retention in care among South African men through U=U messaging: A study protocol for two sequential hybrid type 1 effectiveness- implementation randomized controlled trials. Res Sq [Preprint]. 2023 Oct 4:rs.3.rs-3349696. doi: 10.21203/rs.3.rs-3349696/v1. PMID: 37886512; PMCID: PMC10602079.
Mena Lora AJ, Long JE, Huang Y, Baden LR, El Sahly HM, Follmann D, Goepfert P, Gray G, Grinsztejn B, Kotloff K, Rouphael N, Sobieszczyk M, Walsh SR, Andriesen J, Shah KA, Zhang Y, Gilbert P, Janes H, Gay CL, Falsey AR, Tripp RL, Gorman RL, Tong T, Marovich M, Neuzil K, Corey L, Kublin JG; COVID-19 Prevention Network. Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. JAMA Netw Open. 2023 Jan 3;6(1):e2251974. doi: 10.1001/jamanetworkopen.2022.51974.PMID: 36689221
Merrill KG, Atujuna M, Emerson E, Blachman-Demner D, Bray BC, Bekker LG, Donenberg GR. Preliminary effectiveness and implementation outcomes of the IMARA-South Africa sexual health intervention on adolescent girls and young women: A pilot randomized trial. PLOS Glob Public Health. 2023 Feb 15;3(2):e0001092. doi: 10.1371/journal.pgph.0001092. eCollection 2023.PMID: 36962830
Middelkoop K, Koch AS, Hoosen Z, Bryden W, Call C, Seldon R, Warner DF, Wood R, Andrews JR. Environmental air sampling for detection and quantification of Mycobacterium tuberculosis in clinical settings: Proof of concept. Infect Control Hosp Epidemiol. 2023 May;44(5):774-779. doi: 10.1017/ice.2022.162. Epub 2022 Jul 27. PMID: 35883280.
Middelkoop K, Stewart J, Walker N, Delport C, Jolliffe DA, Coussens AK, Nuttall J, Tang JCY, Fraser WD, Griffiths CJ, Kumar GT, Filteau S, Hooper RL, Wilkinson RJ, Bekker LG, Martineau AR. Vitamin D supplementation to prevent tuberculosis infection in South African schoolchildren: multicenter phase 3 double-blind randomized placebo-controlled trial (ViDiKids). Int J Infect Dis. 2023 Sep;134:63-70. doi: 10.1016/j.ijid.2023.05.010. Epub 2023 May 20. PMID: 37211272.
Miller AP, Shoptaw S, Moucheraud C, Mvududu R, Essack Z, Gorbach PM, Myer L, Davey DLJ. Recent Alcohol Use Is Associated With Increased Pre-exposure Prophylaxis (PrEP) Continuation and Adherence Among Pregnant and Postpartum Women in South Africa. J Acquir Immune Defic Syndr. 2023 Mar 1;92(3):204-211. doi: 10.1097/QAI.0000000000003133. PMID: 36413977; PMCID: PMC9928886.
Miller AP, Shoptaw S, Mvududu R, Mashele N, Coates TJ, Bekker LG, Essack Z, Groenewald C, Petersen Z, Gorbach PM, Myer L, Joseph Davey DL. Sexual Risk among Pregnant Women at Risk of HIV Infection in Cape Town, South Africa: What Does Alcohol Have to Do with It? AIDS Behav. 2023 Jan;27(1):37-50. doi: 10.1007/s10461-022-03742-1. Epub 2022 Jun 23. PMID: 35737280; PMCID: PMC9780404.
Mirembe BG, Cabrera MV, van der Straten A, Nakalega R, Cobbing M, Mgodi NM, Palanee-Phillips T, Mayo AJ, Dadabhai S, Mansoor LE, Siva S, Nair G, Chinula L, Akello CA, Nakabiito C, Soto-Torres LE, Baeten JM, Brown ER. Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial. AIDS Behav. 2023 Mar;27(3):1030-1043. doi: 10.1007/s10461-022-03841-z. Epub 2022 Sep 6. PMID: 36066762; PMCID: PMC10102709.
Moore M, Stansfield S, Donnell DJ, Boily MC, Mitchell KM, Anderson PL, Delany-Moretlwe S, Bekker LG, Mgodi NM, Celum CL, Dimitrov D. Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence. Nat Med. 2023 Nov;29(11):2748-2752. doi: 10.1038/s41591-023-02564-5. Epub 2023 Oct 5. PMID: 37798438.
Moyo-Gwete T, Richardson SI, Keeton R, Hermanus T, Spencer H, Manamela NP, Ayres F, Makhado Z, Motlou T, Tincho MB, Benede N, Ngomti A, Baguma R, Chauke MV, Mennen M, Adriaanse M, Skelem S, Goga A, Garrett N, Bekker LG, Gray G, Ntusi NAB, Riou C, Burgers WA, Moore PL. Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection. medRxiv [Preprint]. 2023 Mar 15:2023.03.15.23287288. doi: 10.1101/2023.03.15.23287288. Update in: PLoS Pathog. 2023 Nov 9;19(11):e1011772. doi: 10.1371/journal.ppat.1011772. PMID: 36993404; PMCID: PMC10055608.
Mukora R, Maraba N, Orrell C, Jennings L, Naidoo P, Mbatha MT, Velen K, Fielding K, Charalambous S, Chetty-Makkan CM. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa. BMJ Open. 2023 Mar 3;13(3):e065202. doi: 10.1136/bmjopen-2022-065202. PMID: 36868589; PMCID: PMC9990642.
Mukora R, Maraba N, Orrell C, Jennings L, Naidoo P, Mbatha MT, Velen K, Fielding K, Charalambous S, Chetty-Makkan CM. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa. BMJ Open. 2023 Mar 3;13(3):e065202. doi: 10.1136/bmjopen-2022-065202. PMID: 36868589; PMCID: PMC9990642.
Nair G, Celum C, Szydlo D, Brown ER, Akello CA, Nakalega R, Macdonald P, Milan G, Palanee-Phillips T, Reddy K, Tahuringana E, Muhlanga F, Nakabiito C, Bekker LG, Siziba B, Hillier SL, Baeten JM, Garcia M, Johnson S, McClure T, Levy L, Livant E, Jacobson C, Soto-Torres L, van der Straten A, Hosek S, Rooney JF, Steytler J, Bunge K, Parikh U, Hendrix C, Anderson P, Ngure K; REACH Protocol Team. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial. Lancet HIV. 2023 Dec;10(12):e779-e789. doi: 10.1016/S2352-3018(23)00227-8. Epub 2023 Oct 25. PMID: 37898146; PMCID: PMC10756058.
Nardell MF, Sindelo S, Rousseau E, Siko N, Fuzile P, Julies R, Bassett IV, Mellins CA, Bekker LG, Butler LM, Katz IT. Development of “Yima Nkqo,” a community-based, peer group intervention to support treatment initiation for young adults with HIV in South Africa. PLoS One. 2023 Jun 15;18(6):e0280895. doi: 10.1371/journal.pone.0280895. PMID: 37319250; PMCID: PMC10270624.
Ndimande-Khoza MN, Katz AWK, Moretlwe-Delany S, Travill D, Rousseau E, Omollo V, Morton J, Johnson R, Bekker LG, Bukusi EA, Baeten J, Celum C, van der Straten A, Roberts ST. Family influences on oral PrEP use among adolescent girls and young women in Kenya and South Africa. PLoS One. 2023 Nov 14;18(11):e0292529. doi: 10.1371/journal.pone.0292529. PMID: 37963171; PMCID: PMC10645326.
Nightingale S, Ances B, Cinque P, Dravid A, Dreyer AJ, Gisslén M, Joska JA, Kwasa J, Meyer AC, Mpongo N, Nakasujja N, Pebody R, Pozniak A, Price RW, Sandford C, Saylor D, Thomas KGF, Underwood J, Vera JH, Winston A. Cognitive impairment in people living with HIV: consensus recommendations for a new approach. Nat Rev Neurol. 2023 Jul;19(7):424-433. doi: 10.1038/s41582-023-00813-2. Epub 2023 Jun 13. PMID: 37311873.
Norcross C, Ombajo LA, Kassim S, Garrett N, Cresswell FV, Ruzagira E. Long-acting antiretrovirals: research and implementation considerations in Africa. Lancet HIV. 2023 Jul;10(7):e428-e429. doi: 10.1016/S2352-3018(23)00134-0. PMID: 37419566.
Patel P, Celum C, Bekker LG. Implementation of HIV prevention strategies globally. Lancet HIV. 2023 Aug;10(8):e492-e494. doi: 10.1016/S2352-3018(23)00139-X. Epub 2023 Jun 26. PMID: 37385271.
Peters RPH, Mdingi M, Jung H, Mukomana F, Gigi RMS, Medina-Marino A, Klausner JD. Low prevalence of Schistosoma haematobium infection in pregnant women in Buffalo City district. S Afr J Infect Dis. 2023 Jun 15;38(1):521. doi: 10.4102/sajid.v38i1.521. PMID: 37435116; PMCID: PMC10331169.
Pike C, Bekker LG. Interrogating the promise of long-acting HIV pre-exposure prophylaxis. Trends Mol Med. 2023 Feb;29(2):93-98. doi: 10.1016/j.molmed.2022.11.003. Epub 2022 Nov 23. PMID: 36435632.
Pike C, Coakley C, Ahmed N, Lee D, Little F, Padian N, Bekker LG. Goals for girls: a cluster-randomized trial to investigate a school-based sexual health programme amongst female learners in South Africa. Health Educ Res. 2023 Sep 20;38(5):375-391. doi: 10.1093/her/cyad025. PMID: 37405698; PMCID: PMC10516375.
Pike C, Coakley C, Lee D, Daniels D, Ahmed N, Hartmann M, Padian N, Bekker LG. Lessons Learned From the Implementation of a School-Based Sexual Health Education Program for Adolescent Girls in Cape Town, South Africa. Glob Health Sci Pract. 2023 Dec 22;11(6):e2300026. doi: 10.9745/GHSP-D-23-00026. PMID: 38124019; PMCID: PMC10749656.
Pike C, Rousseau E, Bekker LG. Promises and potential pitfalls of long-acting injectable pre-exposure prophylaxis. South Afr J HIV Med. 2023 Jul 27;24(1):1497. doi: 10.4102/sajhivmed.v24i1.1497. PMID: 38089889; PMCID: PMC10713495.
Prudden H, Tatoud R, Slack C, Shattock R, Anklesaria P, Bekker LG, Buchbinder S. Experimental Medicine for HIV Vaccine Research and Development. Vaccines (Basel). 2023 May 11;11(5):970. doi: 10.3390/vaccines11050970. PMID: 37243074; PMCID: PMC10222747.
Reeves DB, Mayer BT, deCamp AC, Huang Y, Zhang B, Carpp LN, Magaret CA, Juraska M, Gilbert PB, Montefiori DC, Bar KJ, Cardozo-Ojeda EF, Schiffer JT, Rossenkhan R, Edlefsen P, Morris L, Mkhize NN, Williamson C, Mullins JI, Seaton KE, Tomaras GD, Andrew P, Mgodi N, Ledgerwood JE, Cohen MS, Corey L, Naidoo L, Orrell C, Goepfert PA, Casapia M, Sobieszczyk ME, Karuna ST, Edupuganti S. High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials. Nat Commun. 2023 Dec 14;14(1):8299. doi: 10.1038/s41467-023-43384-y. Erratum in: Nat Commun. 2024 Mar 22;15(1):2575. doi: 10.1038/s41467-024-46805-8. PMID: 38097552; PMCID: PMC10721814.
Restrepo J, Herrera T, Samakoses R, Reina JC, Pitisuttithum P, Ulied A, Bekker LG, Moreira ED, Olsson SE, Block SL, Hammes LS, Laginha F, Ferenczy A, Kurman R, Ronnett BM, Stoler M, Bautista O, Gallagher NE, Salituro G, Ye M, Luxembourg A. Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and Safety. Pediatrics. 2023 Oct 1;152(4):e2022060993. doi: 10.1542/peds.2022-060993. PMID: 37667847.
Riou C, Bhiman JN, Ganga Y, Sawry S, Ayres F, Baguma R, Balla SR, Benede N, Bernstein M, Besethi AS, Cele S, Crowther C, Dhar M, Geyer S, Gill K, Grifoni A, Hermanus T, Kaldine H, Keeton RS, Kgagudi P, Khan K, Lazarus E, Roux JL, Lustig G, Madzivhandila M, Magugu SF, Makhado Z, Manamela NP, Mkhize Q, Mosala P, Motlou TP, Mutavhatsindi H, Mzindle NB, Nana A, Nesamari R, Ngomti A, Nkayi AA, Nkosi TP, Omondi MA, Panchia R, Patel F, Sette A, Singh U, van Graan S, Venter EM, Walters A, Moyo-Gwete T, Richardson SI, Garrett N, Rees H, Bekker LG, Gray G, Burgers WA, Sigal A, Moore PL, Fairlie L. Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants. medRxiv [Preprint]. 2023 Nov 20:2023.11.20.23298785. doi: 10.1101/2023.11.20.23298785. Update in: PLOS Glob Public Health. 2024 Apr 11;4(4):e0002703. doi: 10.1371/journal.pgph.0002703. PMID: 38045321; PMCID: PMC10690356.
Roberts ST, Mancuso N, Williams K, Nabunya HK, Mposula H, Mugocha C, Mvinjelwa P, Garcia M, Szydlo DW, Soto-Torres L, Ngure K, Hosek S. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis. J Int AIDS Soc. 2023 Nov;26(11):e26189. doi: 10.1002/jia2.26189. PMID: 37936551; PMCID: PMC10630658.
Rose PC, Cotton MF, Otwombe K, Innes S, Nel ED. Liver transient elastography values in healthy South African children. BMC Pediatr. 2023 Jul 13;23(1):355. doi: 10.1186/s12887-023-04170-3. PMID: 37443011; PMCID: PMC10339605.
Rose PC, De la Rey Nel E, Cotton MF, Otwombe K, Browne SH, Frigati LJ, Rabie H, Innes S. Decreased Hepatic Steatosis in South African Adolescents With Perinatal HIV Switching to Dolutegravir-containing Regimens. Pediatr Infect Dis J. 2023 Jul 1;42(7):564-572. doi: 10.1097/INF.0000000000003904. Epub 2023 Mar 14. PMID: 36917035; PMCID: PMC10257761.
Rosenberg NE, Shook-Sa BE, Liu M, Stranix-Chibanda L, Yotebieng M, Sam-Agudu NA, Hudgens MG, Phiri SJ, Mutale W, Bekker LG, Moyo S, Zuma K, Charurat ME, Justman J, Chi BH Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data. Lancet HIV. 2023 Jan 23:S2352-3018(22)00328-9. doi: 10.1016/S2352-3018(22)00328-9. Online ahead of print.PMID: 36702151
Rousseau E, Wu L, Heffron R, Baeten JM, Celum CL, Travill D, Delany-Moretlwe S, Bekker LG, Bukusi E, Omollo V, van der Straten A, O’Malley G, Haberer JE, Morton JF, Johnson RE, Roberts ST. Association of sexual relationship power with PrEP persistence and other sexual health outcomes among adolescent and young women in Kenya and South Africa. Front Reprod Health. 2023 May 30;5:1073103. doi: 10.3389/frph.2023.1073103. PMID: 37325240; PMCID: PMC10266091.
Schaaf HS, Bekker A, Rabie H. Perinatal tuberculosis-An approach to an under-recognized diagnosis. Front Public Health. 2023 Nov 7;11:1239734. doi: 10.3389/fpubh.2023.1239734. PMID: 38026389; PMCID: PMC10661895.
Seaton KE, Huang Y, Karuna S, Heptinstall JR, Brackett C, Chiong K, Zhang L, Yates NL, Sampson M, Rudnicki E, Juraska M, deCamp AC, Edlefsen PT, Mullins JI, Williamson C, Rossenkhan R, Giorgi EE, Kenny A, Angier H, Randhawa A, Weiner JA, Rojas M, Sarzotti-Kelsoe M, Zhang L, Sawant S, Ackerman ME, McDermott AB, Mascola JR, Hural J, McElrath MJ, Andrew P, Hidalgo JA, Clark J, Laher F, Orrell C, Frank I, Gonzales P, Edupuganti S, Mgodi N, Corey L, Morris L, Montefiori D, Cohen MS, Gilbert PB, Tomaras GD. Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition. EBioMedicine. 2023 Jul;93:104590. doi: 10.1016/j.ebiom.2023.104590. Epub 2023 Jun 8. PMID: 37300931; PMCID: PMC10363420.
Singh Y, Castillo-Mancilla J, Madimabe R, Jennings L, Ferraris CM, Robbins RN, Anderson PL, Remien RH, Orrell C. Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa. AIDS Res Ther. 2023 Sep 14;20(1):67. doi: 10.1186/s12981-023-00552-w. PMID: 37705102; PMCID: PMC10500931.
Smith PJ, Daniels J, Bekker LG, Medina-Marino A. What motivated men to start PrEP? A cross-section of men starting PrEP in Buffalo city municipality, South Africa. BMC Public Health. 2023 Mar 2;23(1):418. doi: 10.1186/s12889-023-15306-6. PMID: 36864381; PMCID: PMC9979577.
Stanton, A.M., Hornstein, B.D., Musinguzi, N., Dolotina, B., Orrell, C., Amanyire, G., Bwana, M.B., Asiimwe, S., Cross, A., Psaros, C., Hahn, J.A., Bangsberg, D.R., Haberer, J.E., & Matthews, L.T. for the META study team (in press). Factors associated with changes in alcohol use during pregnancy and the postpartum transition among women living with HIV in South Africa and Uganda. Journal of the Association of Providers of AIDS Care.
Stockton MA, Mazinyo EW, Mlanjeni L, Nogemane K, Ngcelwane N, Sweetland AC, Basaraba C, Bezuidenhout C, Sansbury G, Lovero KL, Gouveia ML, Dos Santos PF, Feliciano P, Fumo W, Suleman A, Oquendo MA, Grobler C, Wall MM, Nobatyi P, Medina-Marino A, Wainberg ML. An Ultra-Brief Proxy Measure for Early Mental and Substance Use Disorders and Suicide Risk Case Detection at the Community and Household Level: An Efficient and Feasible Clinical and Population-level Service Needs Screening Tool. Med Res Arch. 2023 Oct;11(10):10.18103/mra.v11i10.4381. doi: 10.18103/mra.v11i10.4381. Epub 2024 Jan 11. PMID: 39119120; PMCID: PMC11309766.
Stockton MA, Mazinyo EW, Mlanjeni L, Nogemane K, Ngcelwane N, Sweetland AC, Basaraba CN, Bezuidenhout C, Sansbury G, Lovero KL, Olivier D, Grobler C, Wall MM, Medina-Marino A, Nobatyi P, Wainberg ML. Validation of a brief screener for broad-spectrum mental and substance-use disorders in South Africa. Glob Ment Health (Camb). 2023 Dec 21;11:e4. doi: 10.1017/gmh.2023.89. PMID: 38283876; PMCID: PMC10808975.
Trickey A, Johnson LF, Fung F, Bonifacio R, Iwuji C, Biraro S, Bosomprah S, Chirimuta L, Euvrard J, Fatti G, Fox MP, Von Groote P, Gumulira J, Howard G, Jennings L, Kiragga A, Muula G, Tanser F, Wagener T, Low A, Vickerman P. Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studies. BMC Infect Dis. 2023 Dec 19;23(1):889. doi: 10.1186/s12879-023-08902-9. PMID: 38114912; PMCID: PMC10731689.
Vorkoper S, Sam-Agudu NA, Bekker LG, Sturke R. Implementation Science for Eliminating HIV Among Adolescents in High-Burden African Countries: Findings and Lessons Learned from the Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA). AIDS Behav. 2023 May;27(Suppl 1):3-6. doi: 10.1007/s10461-023-04038-8. Epub 2023 Mar 25. PMID: 36964834; PMCID: PMC10039452.
Wara NJ, Mvududu R, Marwa MM, Gómez L, Mashele N, Orrell C, Moucheraud C, Kinuthia J, John-Stewart G, Myer L, Hoffman R, Pintye J, Davey DLJ. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya. J Int AIDS Soc. 2023 May;26(5):e26088. doi: 10.1002/jia2.26088. PMID: 37221983; PMCID: PMC10206415.
Warner DF, Wood R. New tricks for an old dog: opportunities for better tuberculosis control. J Int AIDS Soc. 2023 Mar;26(3):e26081. doi: 10.1002/jia2.26081. PMID: 36951496; PMCID: PMC10035324.
Young AM, Mancuso N, Atujuna M, Tenza S, Chitukuta M, Kemigisha D, Ngure K, van der Straten A, Garcia M, Szydlo D, Soto-Torres L, Roberts ST. Adolescent Girls and Young Women’s Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis. AIDS Behav. 2023 Dec;27(12):3941-3951. doi: 10.1007/s10461-023-04109-w. Epub 2023 Jul 1. PMID: 37392268; PMCID: PMC10598125.